PROPEL Stent To Clear Chronic Sinusitis
A newly FDA-approved tool is reducing the need for multiple surgeries and bringing patients relief from chronic sinusitis.
Stay updated with breaking news from Chronic Sinusitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A newly FDA-approved tool is reducing the need for multiple surgeries and bringing patients relief from chronic sinusitis.
Type 2 inflammation may be causative in bronchiectasis in patients with type 2-high severe asthma. Its early diagnosis is critical to improve outcomes in patients with this dual diagnosis.
Dr. Goldrich has practiced in the Central New Jersey area for over 20 years and comes to ENTA as a highly recognized physician....
Rhinosinusitis without nasal polyps is associated with a poorer, disease-specific, health-related quality of life in patients with COPD.
Abstract: Global Intranasal Drug Delivery Market to Reach $71. 3 Billion by 2026 . ...